A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia
Condition(s):InsomniaLast Updated:April 12, 2021Completed
Hide Studies Not Open or Pending
Condition(s):InsomniaLast Updated:April 12, 2021Completed
Condition(s):Healthy VolunteersLast Updated:October 6, 2014Completed
Condition(s):Sleep Initiation and Maintenance DisordersLast Updated:August 17, 2017Completed
Condition(s):InsomniaLast Updated:February 28, 2012Completed
Condition(s):InsomniaLast Updated:February 11, 2020Completed
Condition(s):Sleep; Sleep Disorders; Insomnia; Alzheimer’s DiseaseLast Updated:November 10, 2020Completed
Condition(s):PhysiologyLast Updated:January 5, 2018Completed
Condition(s):Transient InsomniaLast Updated:June 5, 2019Completed
Condition(s):Sleep; MemoryLast Updated:August 26, 2014Completed
Condition(s):Breast Cancer; Hot Flashes; Sleep DisordersLast Updated:April 28, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.